Skip to main content
Download PDF

Prevalence and associated health and lifestyle factors of myopic maculopathy in northern China: the Kailuan eye study

BMC Ophthalmology volume 23, Article number: 176 (2023) Cite this article

Abstract

Background

To evaluate the prevalence and associated health and lifestyle factors of myopic maculopathy (MM) in a northern Chinese industrial city.

Methods

The cross-sectional Kailuan Eye Study included subjects who participated in the longitudinal Kailuan Study in 2016. Ophthalmologic and general examinations were performed on all the participants. MM was graded based on fundus photographs using the International Photographic Classification and Grading System. The prevalence of MM was evaluated. Univariate and multiple logistic regression were adopted to evaluated risk factors of MM.

Results

The study included 8330 participants with gradable fundus photographs for MM and ocular biometry data. The prevalence of MM was 1.11% (93/8330; 95% confidence interval [CI] 0.89–1.33%). Diffuse chorioretinal atrophy, patchy chorioretinal atrophy, macular atrophy, and plus lesions were observed in 72 (0.9%), 15 (0.2%), 6 (0.007%), and 32 eyes (0.4%), respectively. MM was more common in eyes with longer axial length (OR 4.517; 95%CI 3.273 to 6.235) and in participants with hypertension (OR 3.460; 95%CI 1.152 to 10.391), and older age (OR 1.084; 95%CI 1.036 to 1.134).

Conclusions

The MM was present in 1.11% of the northern Chinese individuals 21 years or older and the associate factors include longer axial length, older age, and hypertension.

Peer Review reports

Backgroud

Myopia has been a public health problem worldwide, especially in Asian countries [1,2,3,4]. Several studies reported that myopia related blinding complications are the leading cause of irreversible visual impairment [5,6,7]. It was estimated that up to 55.7 million people will have visual impairment, and up to 18.5 million people will be blind, associated with myopic maculopathy (MM) worldwide in 2050 [8].

The reported prevalence of MM in adult populations ranges from 0.2–3.8%[9,10,11,12,13,14,15,16] in previous studies worldwide and was higher among people with high myopia ranging from 13.3–72.7% [10, 12,13,14]. The risk factors of MM reported in previous studies were older age [9, 10, 12, 13], greater myopic refractive error [9, 10, 12,13,14,15] and longer axial length (AL) [9, 13, 15]. However, other relevant demographic factors, such as gender, education level and lifestyle parameters, such as smoking status, alcohol consumption and physical activity have yet to be comprehensively investigated.

Thus, we aim to determine the prevalence and associated health and lifestyle factors of MM in the industrial city of northern China.

Methods

Participants and setting

The Kailuan Eye Study is a cross-sectional study included participants who had undergone ophthalmologic and general examinations from the longitudinal Kailuan Study. The study population included employees and retirees of a coal mining company (Kailuan Group Company). The community of Kailuan located in the city of Tangshan with approximately 7.2 million inhabitants. The Tangshan city is situated approximately 150 km southeast of Beijing and is a center of the coal mining industry. Using the data from the longitudinal Kailuan Study, cluster sampling was performed in this study. The details of the sampling frame and methods were described elsewhere [17]. At baseline, the study population consisted of 14,440 individuals with an age ranging between 21 and 97 years. The examination in the present study were performed repeatedly at 2-year intervals [17, 18]. The study followed the tenets of the Declaration of Helsinki. The present study was approved by the Medical Ethics Committee of the Beijing Tongren Hospital, and informed consent was obtained from the individuals after explanation of the nature and possible consequences of the study.

Ophthalmological and body examinations

The ophthalmologic examinations [19] which described in detail previously included measurement of visual acuity, tonometry, slit-lamp assisted biomicroscope of the anterior segment of the eye, ocular biometry applying optical low-coherence reflectometry (Lenstar 900 Optical Biometer; Haag-Streit, Koeniz, Switzerland) for the determination of the central corneal thickness, anterior chamber depth, lens thickness and axial length (AL). Al the optical biometry measurement was performed three times repeatedly and the coefficient of variation for all biometric measurements were less than 0.1. Using a nonmydriatic fundus camera (CR6-45NM; Canon, Inc., Osta, Tokyo, Japan), Simultaneous stereoscopic 45° color fundus photographs centered on the optic disc and on the macula were taken for each eye. If the pupil diameter did not allow taking fundus photographs with sufficient photographic quality, we dilated the pupil medically by applying eye drops containing 0.5% tropicamide and 0.5% phenylephrine hydrochloride.

Body height and weight and the circumference of the waist and hip were measured. The body mass index (BMI) and waist–hip ratio was calculated. The smoking index was calculated by multiplying the number of cigarettes per day by the number of years of smoking.

Blood pressure was assessed with the participants sitting for at least 5 min. Blood samples were collected under fasting conditions to determine the blood glucose, high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), triglyceride (TC), and total cholesterol (TG) concentrations [20].

For all participants, an interview was performed with standardized questions about known major systemic diseases and lifestyle parameters. Systemic diseases included hypertension, diabetes mellitus (DM), hyperlipidemia. Lifestyle parameters included smoking status, nature of job, and smart phone usage.

The diagnosis of DM was based on any of the following three criteria: measurement of the fasting blood glucose concentration of 7.0 mmol/L, a self-reported history of DM, or a history of medication with hypoglycemic agents.

The diagnostic criteria for hypertension were blood pressure of ≥ 140/90 mmHg, positive history of hypertension, or the use of antihypertensive drugs.

The diagnostic criteria for hyperlipidemia included hypercholesterolemia (TG ≥ 6.2 mmol /L), hypertriglyceridemia (TC ≥ 2.3 mmol/L), mixed hyperlipidemia (TG ≥ 6.2 mmol /L and TC ≥ 2.3 mmol/L), and low HDL-C levels (< 1.0 mmol/L). The definitions above have been described in detail in previous literature [20].

Definitions and MM grading

High myopia was defined as AL equal to or more than 26.5 mm [12, 21,22,23] in this study. MM was graded among myopic participants using the International Photographic Classification and Grading System for MM [24]. In brief, MM was classified into five categories based on its severity: no myopic retinal degenerative lesion—category 0 (C0); tessellated fundus only—category 1 (C1); diffuse chorioretinal atrophy—category 2 (C2); patchy chorioretinal atrophy—category 3 (C3); macular atrophy—category 4 (C4). Additional lesions including lacquer cracks (LCs), Fuch’s spot and myopic choroidal neovascularisation, that is, ‘plus’ lesions, were also recorded. The presence of MM was defined as C2 or greater, and/or any additional lesions. To evaluate the interobserver agreement of two experienced ophthalmologists (Z.J.Q., W.H.W.), a test set with 100 images from 100 participants with high myopia (60 had C2 or greater MM) was used to test the ophthalmologists. The unweighted kappa was 0.81 for C0/C1, 0.77 for C2, 0.83 for C3, 0.85 for C4, 0.69 for LC, and 0.67 for Fuch’s spot. The two ophthalmologists interpreted each retinal photograph independently using the above-described criteria, and patients with unanimous diagnosis of MM were included in the study.

Statistical analysis

The prevalence of MM with 95% confidence intervals (CIs) were evaluated. Pearson χ2 tests and Mann-Whitney U test were adopted to compare the characteristics between those participants with and without MM. Univariate and multiple logistic regression were adopted to evaluated risk factors for the presence of MM. Odds ratios (ORs) with 95% CIs were calculated. Visual impairment was classified into moderate (decimal: 0.1–0.3), severe (decimal: 0.05–0.1), blindness (decimal: 0.02–0.05) and severe blindness (decimal: less than 0.02). The influence of MM on visual acuity was also evaluated between participants with MM and without these disorders using Pearson χ2 tests. The statistical analysis was performed using SPSS software (version 21.0; IBM/SPSS, Chicago, IL, USA). A p value < 0.05 was regarded as statistically significant.

Result

Only participants with gradable fundus photographs for MM and AL data were included in this study. In the baseline examination of 14,440 participants, 11,648 (80.7%) had gradable binocular fundus photographs. Among these participants, the data of AL was available in 8330 (71.5%) individuals, so that eventually 8330 participants were included in the study. There were 5477 men (50.1%) and 2853 women (49.9%) and the mean age was 51.6 ± 13.8(21 to 97 years) years.

The prevalence of high myopia was 3.19% (266/8330; 95% CI 2.81–3.57%) and the prevalence of MM was 1.11% (93/8330; 95% CI 0.89–1.33%) in the whole population. The prevalence of MM in high myopic participants was 34.96% (93/266; 95% CI 29.23–40.69%), and the MM prevalence increased with the AL (Fig. 1) and with the age (Fig. 2). A total of 125 MM lesions were identified in 93 eyes, including diffuse chorioretinal atrophy (n = 72), patchy chorioretinal atrophy (n = 15), macular atrophy (n = 6), and plus lesions (n = 32). The plus lesions included lacquer cracks (n = 20, 62.50%), Fuch’s spot (n = 7, 21.88%) and myopic choroidal neovascularization (n = 5, 15.62%).

Fig. 1
figure 1

Prevalence of myopic maculopathy in relation to axial length (266 high myopic eyes)

Full size image
Fig. 2
figure 2

Prevalence of myopic maculopathy in relation to age (266 high myopic eyes)

Full size image

Table 1 showed the age-specific and gender-specific prevalence of MM. The characteristics of eyes with or without MM (clinically significant MM) are shown in Table 2. Subjects with MM were older (62.4 ± 13.6 years vs. 51.6 ± 13.9, p < 0.001), had longer AL (27.41 ± 1.12 mm vs. 23.67 ± 1.15 mm, p < 0.001), had higher systolic blood pressure (144.5 ± 17.1 mmHg vs. 136.9 ± 22.6 mm, p = 0.001), had higher rate of hyperlipidemia (2.5% vs. 0.9%, p = 0.007), mental labor (1.5% vs. 0.7%, p = 0.009) and using smart phone (1.3% vs. 0.9%, p = 0.031) than those without MM. There was no statistically significant difference attributable to gender (p = 0.443), diastolic blood pressure (p = 0.383), body mass index (p = 0.863), waist-hip ratio (p = 0.894), smoking index (p = 0.960), and diabetes (p = 0.686) between participants with MM and those without MM.

Table 1 Age-specific and gender-specific prevalence of myopic maculopathy lesions
Full size table
Table 2 Differences between the participants with myopic maculopathy and without myopic maculopathy
Full size table

The univariate analysis in Table 3 involved the parameters which was significantly different in eyes with and without MM in Table 2. Table 3 showed the univariate logistic regression model which demonstrated that older age (OR 1.063; 95% CI 1.045 to 1.080), axial length (OR 5.473; 95% CI 4.419 to 6.777), systolic blood pressure (OR 1.007; 95% CI 1.001 to 1.012), hyperlipidemia (OR 2.999; 95% CI 1.407 to 6.396), mental labor (OR 2.324; 95% CI 1.216 to 4.441), and using smart phone (OR 0.460; 95% CI 0.224 to 0.946) were significantly associated with MM. Gender, body mass index, waist-hip ratio, smoking index, and diabetes did not correlate with the presence of MM.

Table 3 Univariate logistic regression analysis of risk factors associated with myopic maculopathy
Full size table

The multivariable analysis in Table 4 included the presence of MM as dependent parameter and those variables as independent parameters that were associated with the presence of MM in the univariate analysis with a P value < 0.10.Table 4 showed the multiple logistic regression model which demonstrated that older age (OR 1.084; 95% CI 1.036 to 1.134), axial length (OR 4.517; 95% CI 3.273 to 6.235) and Hypertension (OR 3.460; 95% CI 1.152 to 10.391) were significantly associated with MM.

Table 4 Multiple logistic regression analysis of risk factors associated with myopic maculopathy
Full size table

Table 5 explores the impact of MM on visual impairment and blindness. Among 93 participants with MM, only 17 participants (18.3%) showed normal vision for presenting visual acuity; the rest (n = 76, 81.7%) had visual impairment or blindness, including 43 participants (46.2%) who had moderate visual impairment, 20 (21.5%) had severe visual impairment and 13 (14.0%) had blindness.

Table 5 Influence of myopic maculopathy on visual impairment and blindness
Full size table

Discussion

The overall prevalence of MM (1.11%) in this industrial city population was comparable with previous literature, such as that of the Yangxi Eye Study in south China (1.2%, N = 4469, aged ≥ 50 years), Handan Eye Study in north China(0.9%, N = 6603; aged ≥ 30 years), Hisayama Eye Study in Japan (1.7%, N = 1892; aged ≥ 40 years), and Blue Mountains Eye Study in Australia (1.2%, N = 3583; aged ≥ 49 years) [11, 13, 14, 25], but lower than that reported from the the Beijing Eye Study in north China(3.1%, N = 4319; aged ≥ 40 years) and Shihpai Eye Study in Taiwan (3.0%, N = 1058, aged ≥ 65 years) [10, 12]. Different age compositions in these study samples may influence the prevalence findings. In addition, the definition of MM among different studies were not consistent. These two important factors may contribute to the relative lower prevalence of current study [16]. Table 6 shows the comparison of prevalence of MM in different studies.

The risk of MM is higher in persons of older age, regardless of myopia severity and AL, which places MM as an age-related degenerative disease [26,27,28]. This is consistent with our findings, reporting an increase of prevalence with higher age (OR = 1.084 per year). Although MM occurs more often in older age, younger age may also be affected, which reported by Koh et al. in 593 high myopic eyes with a mean age of 21 years [29]. The greater prevalence of MM at an early age might reflect the genetic-driven early manifestations and early progression to high myopia in Asian young man may pose an additional risk factor for MM. Congruently, Chen et al. reported that the pattern of myopic lesions was age-specific: younger age was associated with lacquer cracks (OR 0.96, 95% CI 0.95 to 0.98, p < 0.001), while diffuse and patchy chorioretinal atrophy, macular atrophy and choroidal neovascularisation were more prevalent in older age [30].

In our study, the definition of AL was a prerequisite for myopic maculopathy cases. This approach increased the specificity for myopia-related maculopathy and diminished the issue in subjects with ambiguous fundus findings, and thus reduced ascertainment bias. Increasing AL was associated with a higher prevalence of myopic maculopathy in our study, with an OR of 4.517 comparing eyes with AL 26.5 mm or more compared with less than 26.5 mm. Our results mirrored other studies reporting an increase of MM with longer AL in a dose–response manner [9,10,11, 13, 15, 31]. Axial myopia is consistently held responsible for the development of myopic maculopathy [32].

The general health status and lifestyle habits parameters were also considered in the current study and the results showed that the risk of MM associated with hypertension. The Shihpai eye study reported an association with high blood pressure [12] which is consistent with our findings. Recent studies showed that systolic blood pressure played a significant role on the choroidal thickness change in normal subjects [33, 34]. Higher systolic blood pressure was associated with thinner choroidal thickness [34]. The high blood pressure in myopic patients may further compromise the already thinner choroid [35], interfere with the choroidal circulation, and hence increase the severity of maculopathy. Our finding of hypertension as risk factors needs further verification in longitudinal cohort studies. Future interventional studies or clinical studies might consider including blood pressure measurement for analysis. However, we could not find association of Diabetes, serum lipids, BMI, smoking, nature of job (mental or physical), and using smart phone (near distance working) with MM after multivariable adjustment in the present study. These findings are consistent with the results from Wong et al [36].

Table 6 Comparison of prevalence of myopic maculopathy in different studies
Full size table

It has been demonstrated that MM was the leading cause of bilateral visual impairment and blindness [2,3,4, 28]. Our study mirrored this link between MM and visual impairment and blindness, with 81.7% (76/93) of participants with MM having a present visual acuity classified as visual impairment or blindness. Subjects with MM had significantly poorer visual acuity than subjects without MM(P < 0.001).

Strengths of this study include large sample size, the use of International Photographic Classification and Grading System for MM, reasonable response rates (71.5%), and standardized methodology for data collection, ocular biometry assessment, and fundus photography. Our study was limited in several aspects. On account of unable to acquire enough data of their spherical equivalent, we used a strict definition for high myopia (axial length ≧ 26.5 mm). This cutoff was adopted in several studies as the definition of high myopia [12, 21,22,23]. The prevalence of high myopia might have been underestimated to some extent. However, we believe the effect of including the axial length as a defining characteristic in the prevalence of MM is minimal if any. Furthermore, studies showed that there were significantly more retinal complications in eyes with axial length longer than 26.5 mm [21, 37,38,39]. As we did not perform OCT imaging, we cannot state on the ATN classification system [23] in which not only the atrophic (A) and neovascular (N) components of pathological myopia were included, but also the aspect of traction (T).

Conclusions

In summary, the prevalence of clinical MM was present in 1.11% of the Chinese people at age 21–97 years in Kailuan area in northern China and 34.96% of high myopic people. MM was associated with longer axial length, with older age, and with hypertension.

Data availability

The datasets used and/or analysed during the current study available from the corresponding author on reasonable request.

Abbreviations

MM:

myopic maculopathy

AL:

axial length

BMI:

body mass index

HDL-C:

high-density lipoprotein cholesterol

LDL-C:

low-density lipoprotein cholesterol

TC:

triglyceride

TG:

total cholesterol

DM:

diabetes mellitus

CI:

confidence interval

OR:

Odds ratio.

References

  1. Holden B, Sankaridurg P, Smith E, Aller T, Jong M, He M. Myopia, an underrated global challenge to vision: where the current data takes us on myopia control. Eye (Lond). 2014;28(2):142–6.

    Article  CAS  PubMed  Google Scholar 

  2. Holden BA, Fricke TR, Wilson DA, Jong M, Naidoo KS, Sankaridurg P, Wong TY, Naduvilath TJ, Resnikoff S. Global prevalence of myopia and high myopia and temporal Trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036–42.

    Article  PubMed  Google Scholar 

  3. Holden BA, Jong M, Davis S, Wilson D, Fricke T, Resnikoff S. Nearly 1 billion myopes at risk of myopia-related sight-threatening conditions by 2050 - time to act now. Clin Exp Optom. 2015;98(6):491–3.

    Article  PubMed  Google Scholar 

  4. Holden BA, Wilson DA, Jong M, Sankaridurg P, Fricke TR, Smith EL III, Resnikoff S. Myopia: a growing global problem with sight-threatening complications. Community Eye Health. 2015;28(90):35.

    PubMed  PubMed Central  Google Scholar 

  5. Morgan IG, Ohno-Matsui K, Saw SM. Myopia. Lancet. 2012;379(9827):1739–48.

    Article  PubMed  Google Scholar 

  6. Foster PJ, Jiang Y. Epidemiology of myopia. Eye (Lond). 2014;28(2):202–8.

    Article  CAS  PubMed  Google Scholar 

  7. Warner N. Update on myopia. Curr Opin Ophthalmol. 2016;27(5):402–6.

    Article  PubMed  Google Scholar 

  8. Fricke TR, Jong M, Naidoo KS, Sankaridurg P, Naduvilath TJ, Ho SM, Wong TY, Resnikoff S. Global prevalence of visual impairment associated with myopic macular degeneration and temporal trends from 2000 through 2050: systematic review, meta-analysis and modelling. Br J Ophthalmol. 2018;102(7):855–62.

    Article  PubMed  Google Scholar 

  9. Wong YL, Sabanayagam C, Ding Y, Wong CW, Yeo AC, Cheung YB, Cheung G, Chia A, Ohno-Matsui K, Wong TY et al. Prevalence, Risk Factors, and Impact of Myopic Macular Degeneration on Visual Impairment and Functioning Among Adults in Singapore. Invest Ophthalmol Vis Sci 2018, 59(11):4603–4613.

  10. Liu HH, Xu L, Wang YX, Wang S, You QS, Jonas JB. Prevalence and progression of myopic retinopathy in chinese adults: the Beijing Eye Study. Ophthalmology. 2010;117(9):1763–8.

    Article  PubMed  Google Scholar 

  11. Gao LQ, Liu W, Liang YB, Zhang F, Wang JJ, Peng Y, Wong TY, Wang NL, Mitchell P, Friedman DS. Prevalence and characteristics of myopic retinopathy in a rural chinese adult population: the Handan Eye Study. Arch Ophthalmol. 2011;129(9):1199–204.

    Article  PubMed  Google Scholar 

  12. Chen SJ, Cheng CY, Li AF, Peng KL, Chou P, Chiou SH, Hsu WM. Prevalence and associated risk factors of myopic maculopathy in elderly Chinese: the Shihpai eye study. Invest Ophthalmol Vis Sci. 2012;53(8):4868–73.

    Article  PubMed  Google Scholar 

  13. Asakuma T, Yasuda M, Ninomiya T, Noda Y, Arakawa S, Hashimoto S, Ohno-Matsui K, Kiyohara Y, Ishibashi T. Prevalence and risk factors for myopic retinopathy in a japanese population: the Hisayama Study. Ophthalmology. 2012;119(9):1760–5.

    Article  PubMed  Google Scholar 

  14. Vongphanit J, Mitchell P, Wang JJ. Prevalence and progression of myopic retinopathy in an older population. Ophthalmology. 2002;109(4):704–11.

    Article  PubMed  Google Scholar 

  15. Jonas JB, Nangia V, Gupta R, Bhojwani K, Nangia P, Panda-Jonas S. Prevalence of myopic retinopathy in rural Central India. Acta Ophthalmol. 2017;95(5):e399–e404.

    Article  PubMed  Google Scholar 

  16. Wong YL, Saw SM. Epidemiology of pathologic myopia in Asia and Worldwide. Asia Pac J Ophthalmol (Phila). 2016;5(6):394–402.

    Article  PubMed  Google Scholar 

  17. Wu S, Huang Z, Yang X, Zhou Y, Wang A, Chen L, Zhao H, Ruan C, Wu Y, Xin A, et al. Prevalence of ideal cardiovascular health and its relationship with the 4-year cardiovascular events in a northern chinese industrial city. Circ Cardiovasc Qual Outcomes. 2012;5(4):487–93.

    Article  PubMed  Google Scholar 

  18. Wang L, Cui L, Wang Y, Vaidya A, Chen S, Zhang C, Zhu Y, Li D, Hu FB, Wu S, et al. Resting heart rate and the risk of developing impaired fasting glucose and diabetes: the Kailuan prospective study. Int J Epidemiol. 2015;44(2):689–99.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Wang Q, Wang YX, Wu SL, Chen SH, Yan YN, Yang MC, Yang JY, Zhou WJ, Chan SY, Zhang XH, et al. Ocular axial length and Diabetic Retinopathy: the Kailuan Eye Study. Invest Ophthalmol Vis Sci. 2019;60(10):3689–95.

    Article  CAS  PubMed  Google Scholar 

  20. Yongpeng Z, Yaxing W, Jinqiong Z, Qian W, Yanni Y, Xuan Y, Jingyan Y, Wenjia Z, Ping W, Chang S, et al. The Association between Diabetic Retinopathy and the prevalence of age-related Macular Degeneration-The Kailuan Eye Study. Front Public Health. 2022;10:922289.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Percival SP. Redefinition of high myopia: the relationship of axial length measurement to myopic pathology and its relevance to cataract surgery. Dev Ophthalmol. 1987;14:42–6.

    Article  CAS  PubMed  Google Scholar 

  22. Shih YF, Ho TC, Hsiao CK, Lin LL. Visual outcomes for high myopic patients with or without myopic maculopathy: a 10 year follow up study. Br J Ophthalmol. 2006;90(5):546–50.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Ruiz-Medrano J, Montero JA, Flores-Moreno I, Arias L, Garcia-Layana A, Ruiz-Moreno JM. Myopic maculopathy: current status and proposal for a new classification and grading system (ATN). Prog Retin Eye Res. 2019;69:80–115.

    Article  PubMed  Google Scholar 

  24. Ohno-Matsui K, Kawasaki R, Jonas JB, Cheung CM, Saw SM, Verhoeven VJ, Klaver CC, Moriyama M, Shinohara K, Kawasaki Y, et al. International photographic classification and grading system for myopic maculopathy. Am J Ophthalmol. 2015;159(5):877–883e877.

    Article  PubMed  Google Scholar 

  25. Li Z, Liu R, Jin G, Ha J, Ding X, Xiao W, Xu X, An L, Zhao J, He M. Prevalence and risk factors of myopic maculopathy in rural southern China: the Yangxi Eye Study. Br J Ophthalmol. 2019;103(12):1797–802.

    PubMed  Google Scholar 

  26. Ohno-Matsui K. What Is the Fundamental Nature of Pathologic Myopia? Retina 2017, 37(6):1043–1048.

  27. Ohno-Matsui K, Lai TY, Lai CC, Cheung CM. Updates of pathologic myopia. Prog Retin Eye Res. 2016;52:156–87.

    Article  PubMed  Google Scholar 

  28. Ye L, Chen Q, Hu G, Xie J, Lv H, Shi Y, Yin Y, Zhu J, Fan Y, He J, et al. Distribution and association of visual impairment with myopic maculopathy across age groups among highly myopic eyes - based on the new classification system (ATN). Acta Ophthalmol. 2022;100(4):e957–67.

    Article  PubMed  Google Scholar 

  29. Koh V, Tan C, Tan PT, Tan M, Balla V, Nah G, Cheng CY, Ohno-Matsui K, Tan MM, Yang A, et al. Myopic Maculopathy and Optic Disc Changes in highly myopic young asian eyes and impact on visual acuity. Am J Ophthalmol. 2016;164:69–79.

    Article  PubMed  Google Scholar 

  30. Chen H, Wen F, Li H, Zuo C, Zhang X, Huang S, Luo G. The types and severity of high myopic maculopathy in chinese patients. Ophthalmic Physiol Opt. 2012;32(1):60–7.

    Article  CAS  PubMed  Google Scholar 

  31. Choudhury F, Meuer SM, Klein R, Wang D, Torres M, Jiang X, McKean-Cowdin R, Varma R. Chinese American Eye Study G: prevalence and characteristics of myopic degeneration in an adult chinese American Population: the chinese American Eye Study. Am J Ophthalmol. 2018;187:34–42.

    Article  PubMed  Google Scholar 

  32. Xiao O, Guo X, Wang D, Jong M, Lee PY, Chen L, Morgan IG, Sankaridurg P, He M. Distribution and severity of myopic Maculopathy among highly myopic eyes. Invest Ophthalmol Vis Sci. 2018;59(12):4880–5.

    Article  PubMed  Google Scholar 

  33. Tan CS, Ouyang Y, Ruiz H, Sadda SR. Diurnal variation of choroidal thickness in normal, healthy subjects measured by spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2012;53(1):261–6.

    Article  PubMed  Google Scholar 

  34. Usui S, Ikuno Y, Akiba M, Maruko I, Sekiryu T, Nishida K, Iida T. Circadian changes in subfoveal choroidal thickness and the relationship with circulatory factors in healthy subjects. Invest Ophthalmol Vis Sci. 2012;53(4):2300–7.

    Article  PubMed  Google Scholar 

  35. Wang NK, Lai CC, Chu HY, Chen YP, Chen KJ, Wu WC, Yeh LK, Chuang LH, Chen TL. Classification of early dry-type myopic maculopathy with macular choroidal thickness. Am J Ophthalmol. 2012;153(4):669–77. 677 e661-662.

    Article  PubMed  Google Scholar 

  36. Wong YL, Zhu X, Tham YC, Yam JCS, Zhang K, Sabanayagam C, Lanca C, Zhang X, Han SY, He W, et al. Prevalence and predictors of myopic macular degeneration among asian adults: pooled analysis from the Asian Eye Epidemiology Consortium. Br J Ophthalmol. 2021;105(8):1140–8.

    Article  PubMed  Google Scholar 

  37. Curtin BJ, Karlin DB. Axial length measurements and fundus changes of the myopic eye. Am J Ophthalmol. 1971;71(1 Pt 1):42–53.

    Article  CAS  PubMed  Google Scholar 

  38. Nguyen HTT, Hoang TT, Pham CM, Nguyen TM, Dang TM, Fricke TR. Prevalence and related factors of myopic retinopathy - a hospital-based cross-section study in Vietnam.Clin Exp Optom2022:1–4.

  39. Du R, Xie S, Igarashi-Yokoi T, Watanabe T, Uramoto K, Takahashi H, Nakao N, Yoshida T, Fang Y, Ohno-Matsui K. Continued increase of axial length and its risk factors in adults with high myopia. JAMA Ophthalmol. 2021;139(10):1096–103.

    Article  PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

Supported by the National Natural Science Foundation of China (82220108017, 82141128); The Capital Health Research and Development of Special (2020-1-2052); Science & Technology Project of Beijing Municipal Science & Technology Commission (Z201100005520045, Z181100001818003).

Author information

Authors and Affiliations

  1. Beijing Tongren Eye Center, Beijing key Laboratory of Intraocular Tumor Diagnosis and Treatment, Beijing Ophthalmology & Visual Sciences Key Lab, Medical Artificial Intelligence Research and Verification Key Laboratory of the Ministry of Industry and Information Technology, Beijing Tongren Hospital, Beijing Tongren Eye Center, Capital Medical University, Beijing, China

    Haiwei Wang, Jinqiong Zhou, Qian Wang, Yanni Yan, Xuan Yang, Jingyan Yang, Wenjia Zhou, Zihan Nie, Xuhan Shi, Haixia Ji, Yongpeng Zhang, Xuehui Shi & Wen-Bin Wei

  2. Department of Ophthalmology, Fuxing Hospital, Capital Medical University, Beijing, China

    Haiwei Wang

  3. Beijing Institute of Ophthalmology, Beijing Key Laboratory of Ophthalmology and Visual Sciences, Beijing Tongren Hospital, Beijing Tongren Eye Center, Capital Medical University, Beijing, China

    Ya Xing Wang

Authors
  1. Haiwei Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Jinqiong Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ya Xing Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Qian Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yanni Yan
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Xuan Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jingyan Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Wenjia Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Zihan Nie
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Xuhan Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Haixia Ji
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Yongpeng Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Xuehui Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Wen-Bin Wei
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Conceived and designed the experiments: HW, YW, WW. Performed the experiments: YW, QW, JY, ZN, WZ, XS. Analysed the data: HW, JZ, Contributed reagents/materials/analysis tools: HJ, YZ. Wrote the paper: HW. Discussion of the results and critical review of the manuscript: HW, JZ, YW, WW. All authors have read and approved the manuscript.

Corresponding author

Correspondence to Wen-Bin Wei.

Ethics declarations

Ethics approval and consent to participate

The present study was approved by the Medical Ethics Committee of the Beijing Tongren Hospital, and informed consent was obtained from the individuals after explanation of the nature and possible consequences of the study.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wang, H., Zhou, J., Wang, Y.X. et al. Prevalence and associated health and lifestyle factors of myopic maculopathy in northern China: the Kailuan eye study. BMC Ophthalmol 23, 176 (2023). https://doi.org/10.1186/s12886-023-02896-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12886-023-02896-3

Keywords

BMC Ophthalmology

ISSN: 1471-2415

Contact us